摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-(4-cyclohexylaminomethyl-[1,2,3]triazol-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid | 1416988-28-7

中文名称
——
中文别名
——
英文名称
7-(4-cyclohexylaminomethyl-[1,2,3]triazol-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
英文别名
7-[4-[(Cyclohexylamino)methyl]triazol-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid;7-[4-[(cyclohexylamino)methyl]triazol-1-yl]-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
7-(4-cyclohexylaminomethyl-[1,2,3]triazol-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid化学式
CAS
1416988-28-7
化学式
C22H24FN5O3
mdl
——
分子量
425.463
InChiKey
YXIVHBBMEYEBKP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    31
  • 可旋转键数:
    6
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    100
  • 氢给体数:
    2
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Design and synthesis of new N-substituted amino methyl-[1,2,3] triazolyl moieties of fluoroquinolones as antibacterial agents
    作者:G. Govinda Rajulu、Halehatty S. Bhojya Naik、Abhilash Viswanathan、Devesh S. Agarwal、Ganesh Sambasivam、Kesavan Poonimangadu Koppolu
    DOI:10.1007/s00044-012-0394-2
    日期:2013.8
    A series of twenty new N-substituted amino methyl-[1,2,3] triazolyl derivatives at C-7 position of fluoroquinolones were designed and synthesized through multistep synthesis. The synthesized compounds were characterized by H-1 NMR, C-13 NMR, ESI-MS, and IR. The antibacterial activities of these new fluoroquinolones were evaluated using a standard broth micro dilution technique. Out of the twenty derivatives, aryl substituted amino derivatives (6m to 6q) exhibited very good potency in inhibiting the growth of Methicillin-sensitive Staphylococcus aureus (MSSA), Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococcus faecalis (VRE faecalis) (MIC: 0.25-4.00 mu g/mL) as compared to the marketed drugs Linezolid and Ciprofloxacin.
查看更多